Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005340
Filing Date
2014-11-10
Accepted
2014-11-10 08:36:02
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aspx-10q_20140930.htm 10-Q 1504866
2 EX-31.1 aspx-ex311_201409306.htm EX-31.1 8249
3 EX-31.2 aspx-ex312_201409307.htm EX-31.2 8149
4 EX-32.1 aspx-ex321_201409308.htm EX-32.1 8683
  Complete submission text file 0001564590-14-005340.txt   7135468

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aspx-20140930.xml EX-101.INS 1126381
6 XBRL TAXONOMY EXTENSION SCHEMA aspx-20140930.xsd EX-101.SCH 46494
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aspx-20140930_cal.xml EX-101.CAL 54979
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aspx-20140930_def.xml EX-101.DEF 118341
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aspx-20140930_lab.xml EX-101.LAB 324549
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aspx-20140930_pre.xml EX-101.PRE 249881
Mailing Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037
Business Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Filer) CIK: 0001454189 (see all company filings)

EIN.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36292 | Film No.: 141206685
SIC: 2834 Pharmaceutical Preparations